Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib maintenance in platinum-sensitive relapsed ovarian cancer (NORA)
NCT03705156Phase 3Unknown
- Sponsor
- Zai Lab
- Start
- Jun 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niraparib in ovarian cancer, sponsored by Zai Lab. Status: unknown.
02
Drugs
niraparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03705156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03705156.